This is a preview of subscription content, log in via an institution to check access.
References
Adler S (1964)Leishmania. Adv Parasitol 2:35–96
Adler S, Foner A, Montiglio B (1966) The relationship between human and animal strains ofLeishmania from the Sudan. Trans R Soc Trop Med Hyg 60:380–386
Badaró R, Reed SG, Carvalho EM (1983) Immunofluorescent antibody test in American visceral leishmaniasis: sensitivity and specificity of different morphological forms of twoLeishmania species. Am J Trop Med Hyg 32:480–484
Bordier C (1981) Phase-separation of integral membrane proteins. J Biol Chem 256:1604–1607
Brenner Z (1973) The biology ofTrypanosoma cruzi. Annu Rev Microbiol 27:347–381
Dos Santos JI, Morgado MG, Galvão-Castro B (1987) Human visceral leishmaniasis: analysis of the specificity of humoral immune response to polypeptides ofLeishmania donovani chagasi. Am J Trop Med Hyg 37:263–270
Garnham PCC, Humphrey JH (1969) Problems in leishmaniasis related to immunology. Curr Top Microbiol Immunol 48:29–42
Grimaldi G Jr, David JR, McMahon-Pratt D (1987) Identification and distribution of New WorldLeishmania species characterized by serodema analysis using monoclonal antibodies. Am J Trop Med Hyg 36:270–287
Kipnis TL, David JR, Alper CA, Dias da Silva W (1981) Enzymatic treatment transforms trypomastigotes ofTrypanosoma cruzi into activators of the alternative complement pathway and potentiates their uptake by macrophages. Proc Natl Acad Sci USA 78:602–605
Krettli AU, Cançado JR, Brenner Z (1984) Effect of specific chemotherapy on the levels of lytic antibodies in Chagas' disease. Trans R Soc Trop Med Hyg 76:334–340
Mitchel GF, Curtis JM, Handman E, McKenzie IFC (1980) Cutaneous leishmaniasis in mice. Disease patterns in reconstituted nude mice of several genotypes infected withLeishmania tropica. Aust J Exp Biol Med Sci 58:521–532
Nogueira N, Bianco C, Cohn Z (1975) Studies on the selective lysis and purification ofTrypanosoma cruzi. J Exp Med 142:224–229
Pearson RD, Steigbigel RT (1980) Mechanism of lethal effect of human serum uponLeishmania donovani. J Immunol 125:2195–2201
Pontes de Carvalho LC, Badaró R, Carvalho EM, Lannes-Vieira J, Vinhaes L, Orge G, Marzochi MCA, Galvão-Castro B (1986) Nature and incidence of erythrocyte-bound IgG and some aspects of the physiopathogenesis of anemia in American visceral leishmaniasis. Clin Exp Immunol 64:495–502
Puentes SM, Sacks DL, Silva da RP, Joiner KA (1988) Complement binding by two developmental stages ofLeishmania major promastigotes varying in expression of a surface lipophosphoglycan. J Exp Med 167:887–902
Puentes SM, Silva da RP, Sacks DL, Hammer CH, Joiner KA (1990) Serum resistance of metacyclic stageLeishmania major promastigotes is due to release of C5b-9. J Immunol 145:4311–4316
Reed SG, Badaró R, Lloyd RM (1987) Identification of specific and cross-reactive antigens ofLeishmania donovani chagasi by human infection sera. J Immunol 128:1596–1601
Sacks DL (1989) Minireview — metacyclogenesis inLeishmania promastigotes. Exp Parasitol 69:100–103
Sadigursky M, Brodskyn CI (1986) A new liquid medium without blood and serum for culture of hemoflagellates. Am J Trop Med Hyg 35:942–944
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Soares, N.M., Carvalho, E.M., Pinho, R.T. et al. Induction of complement-sensitivity inLeishmania amazonensis metacyclic promastigotes by protease treatment but not by specific antibodies. Parasitol Res 79, 340–342 (1993). https://doi.org/10.1007/BF00932193
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00932193